We recommend a BUY on Zensar, aided by strong revenue growth momentum and better recovery. We assign 14.8x P/E multiple to its FY24E earnings of Rs. 24.25 per share to arrive at a TP of Rs 360 per share, implying an upside of 25% from CMP.